Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

98 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Additional chromosome abnormalities in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy.
Cervera J, Montesinos P, Hernández-Rivas JM, Calasanz MJ, Aventín A, Ferro MT, Luño E, Sánchez J, Vellenga E, Rayón C, Milone G, de la Serna J, Rivas C, González JD, Tormo M, Amutio E, González M, Brunet S, Lowenberg B, Sanz MA. Cervera J, et al. Among authors: ferro mt. Haematologica. 2010 Mar;95(3):424-31. doi: 10.3324/haematol.2009.013243. Epub 2009 Nov 10. Haematologica. 2010. PMID: 19903674 Free PMC article.
Additional cytogenetic changes do not influence the outcome of patients with newly diagnosed acute promyelocytic leukemia treated with an ATRA plus anthracyclin based protocol. A report of the Spanish group PETHEMA.
Hernández JM, Martín G, Gutiérrez NC, Cervera J, Ferro MT, Calasanz MJ, Martínez-Climent JA, Luño E, Tormo M, Rayón C, Díaz-Mediavilla J, González M, González-San Miguel JD, Pérez-Equiza K, Rivas C, Esteve J, Alvarez Mdel C, Odriozola J, Ribera JM, Sanz MA; PETHA Cooperative Group, Spain. Hernández JM, et al. Among authors: ferro mt. Haematologica. 2001 Aug;86(8):807-13. Haematologica. 2001. PMID: 11522536
Two cases of myeloid disorders and a t(8;12) (q12;p13).
Hernández JM, González MB, García JL, Ferro MT, Gutiérrez NC, Marynen P, San Miguel JF. Hernández JM, et al. Among authors: ferro mt. Haematologica. 2000 Jan;85(1):31-4. Haematologica. 2000. PMID: 10629588
Stage, percentage of basophils at diagnosis, hematologic response within six months, cytogenetic response in the first year: the main prognostic variables affecting outcome in patients with chronic myeloid leukemia in chronic phase treated with interferon-alpha. Results of the CML89 trial of the Spanish Collaborative Group on interferon-alpha2a and CML.
Steegmann JL, Odriozola J, Rodriguez-Salvanés F, Giraldo P, García-Laraña J, Ferro MT, Benítez E, Pérez-Pons C, Giralt M, Escribano L, Lavilla E, Miguel A, Areal C, Pérez-Encinas M, Abad A, Maldonado J, Massagué I, Fernández-Rañada JM. Steegmann JL, et al. Among authors: ferro mt. Haematologica. 1999 Nov;84(11):978-87. Haematologica. 1999. PMID: 10553157 Clinical Trial.
Southern technique and cytogenetics are complementary and must be used together in the evaluation of Ph1, M-BCR positive chronic myeloid leukemia (CML) patients treated with alpha interferon (IFN-alpha).
Steegmann JL, Requena MJ, Casado LF, Pico M, Peñarrubia MJ, Ferro MT, Resino M, Fernandez-Rañada JM. Steegmann JL, et al. Among authors: ferro mt. Am J Hematol. 1996 Nov;53(3):169-74. doi: 10.1002/(SICI)1096-8652(199611)53:3<169::AID-AJH4>3.0.CO;2-X. Am J Hematol. 1996. PMID: 8895687 Free article.
Unusual translocations and other changes in acute leukemia.
Ferro MT, del Potro E, Krsnik I, Villegas A, Fernández-Rañada JM, Resino M, García-Sagredo JM, San-Román C. Ferro MT, et al. Cancer Genet Cytogenet. 1991 Jul 15;54(2):163-71. doi: 10.1016/0165-4608(91)90204-8. Cancer Genet Cytogenet. 1991. PMID: 1884348
98 results